ABCB1 and brain neoplasm: As opposed to these previous studies, we examined in the present study patients with non-contrast enhancing, low- to high-grade brain tumors and used a radiolabeled model ABCB1/ABCG2 substrate instead of a drug which is used for treatment of tumors.